Amarin Corp Plc (AMRN)

[alm2]

Kiwi
Not sure I could perform such a calculation - highly complex to assess turnover / cost and profit value to each European country and ROW and indeed what might remain of USA- I would presume Amarin will have made a reasonable stab as to such an assessment - and no doubt if any BO party interested Amarin will share such - although such a party would no doubt have their own view
The point is that there will be share value life after an appeal loss - which if Amarin presents to the market / its shareholders its value vision all can assess and thus determine share price
Amarin post appeal loss has some value - I have read views expressed of equating to 15 dollars a share - yet we are running around 7 - but the reality is that Amarin has not set out their assessment of post appeal financials for an informed assessment to be made
I agree - my general view is considerable value in Europe / ROW/ and what remains USA- certainly above a 7 dollar share value
Maybe Amarin does not want to publish their value view - with a USA win / With a USA loss -at this time
But it would help shareholders greatly to know their vision ahead
Of course it’s hard enough to get their view of even where any given 12 months ahead values lie !
As to European health systems - you summarise accurately - drug value assessments are intense / public purse paying / therefore value of drug in patient treatment paramount
amarin demonstrates immense cost effectiveness but perhaps suffers from being viewed as preventative rather more than curative - convincing to pay for drug use to prevent a condition arising over time maybe somewhat harder than prescribing a magic pill that immediately cures a currently experienced illness ! (Unless you are talking of a covid 19 vaccine
Alm